But what exactly is NAD+, and why arent NAD+ supplements the best option
The Phase Ib/IIa randomized, double-blind, placebo-controlled multicenter RCT (NCT04353791) enrolled 32 patients with moderate to severe UC across 16 locations in Spain and Ukraine, randomizing 24 subjects to receive Oncostellae and 8 to placebo for 28 days
First, it targets the satiety centers in the brain, effectively lowering your appetite and reducing the frequency of food cravings
In addition, regions with limited regulatory oversight or delayed enforcement may experience higher long-term exposure, as companies fail to adequately reduce emissions or upgrade equipment
Initially developed for diabetes, it gained FDA approval in 2021 for chronic weight loss, thanks to successful clinical trials like the STEP program